Inflammatory Myofibroblastic Tumors
Also known as: Inflammatory Myofibroblastic Tumor / Inflammatory myofibroblastic tumour / Inflammatory pseudotumour / Inflammatory Pseudotumor / Inflammatory myofibroblastic tumor (disorder) / Myofibroblastic tumor (morphologic abnormality) / Inflammatory pseudotumor (morphologic abnormality) / Myofibroblastic tumor / Myofibroblastic tumour
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12267 | Brigatinib | 1 / 2 | Recruiting | 1 |
DB12267 | Brigatinib | 1 / 2 | Withdrawn | 1 |
DB09063 | Ceritinib | 2 | Terminated | 1 |
DB08865 | Crizotinib | 2 / 3 | Unknown Status | 1 |
DB00531 | Cyclophosphamide | 2 / 3 | Active Not Recruiting | 1 |
DB00694 | Daunorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB01181 | Ifosfamide | 2 / 3 | Active Not Recruiting | 1 |
DB06589 | Pazopanib | 2 / 3 | Active Not Recruiting | 1 |
DB08865 | Crizotinib | Not Available | No Longer Available | 1 |